Patents Assigned to Solx, Inc.
  • Patent number: 7207965
    Abstract: A system is provided for reducing intraocular hypertension, the system having an implantable shunt, with a planar member having at least one microchannel disposed within the planar member. There is an inflow port disposed proximate to a first end of the microchannel and an outflow port disposed proximate to a second end of the microchannel. The inflow port is configured such that when the implantable shunt is implanted, the inflow port is located approximately within the region of an angle of an anterior chamber.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: April 24, 2007
    Assignee: SOLX, Inc.
    Inventor: Gabriel Simon
  • Publication number: 20060069340
    Abstract: A system is provided for reducing intraocular pressure, the system having: an implantable shunt, the implantable shunt with a planar member, at least one microchannel disposed within that planar member, and a laser whereby at least one fenestration may be introduced into the microchannel.
    Type: Application
    Filed: November 3, 2005
    Publication date: March 30, 2006
    Applicant: SOLX, INC.
    Inventor: Gabriel Simon
  • Patent number: 6989007
    Abstract: A system for non-invasive treatment of a patient's trabecular meshwork to treat primary open-angle glaucoma. The system and technique applies energy directly to media within clogged spaces in a patient's trabecular meshwork to increase aqueous outflow facility by (i) localization of microimplantable bodies carrying a selected exogenous chromophore, such as particles with a gold surface, in deeper regions of the trabecular meshwork, and (ii) irradiation of the microimplantables with a selected coherent wavelength having a power level and pulse duration that is strongly absorbed by the surfaces of the microimplantables.
    Type: Grant
    Filed: January 27, 2004
    Date of Patent: January 24, 2006
    Assignee: Solx, Inc.
    Inventor: John H Shadduck
  • Publication number: 20050165385
    Abstract: Embodiments of the present invention provide a method and system of treating intraocular pressure. Laser light is directed to the ciliary region of the target eye. The light stimulates the ciliary region and ablates debris lodged therein. An immune response may be triggered by the stimulation of the ciliary body. Intraocular pressure is reduced by the increase in aqueous flow from the anterior chamber in the eye permitted by the resultant removal of debris blocking the uveo-scleral outflow pathway.
    Type: Application
    Filed: January 24, 2005
    Publication date: July 28, 2005
    Applicant: SOLX, INC.
    Inventor: Gabriel Simon
  • Publication number: 20040254521
    Abstract: A system is provided for reducing intraocular hypertension, the system comprising an implantable shunt, comprising a planar member having at least one microchannel disposed within the planar member. There is an inflow port disposed proximate to a first end of the microchannel and an outflow port disposed proximate to a second end of the microchannel, wherein the inflow port is configured such that when the implantable shunt is implanted, the inflow port is located about approximately within the region of an angle of an anterior chamber.
    Type: Application
    Filed: June 16, 2004
    Publication date: December 16, 2004
    Applicant: SOLX, INC.
    Inventor: Gabriel Simon